The multifunctional NS1 protein of influenza A viruses
- PMID: 18796704
- DOI: 10.1099/vir.0.2008/004606-0
The multifunctional NS1 protein of influenza A viruses
Abstract
The non-structural (NS1) protein of influenza A viruses is a non-essential virulence factor that has multiple accessory functions during viral infection. In recent years, the major role ascribed to NS1 has been its inhibition of host immune responses, especially the limitation of both interferon (IFN) production and the antiviral effects of IFN-induced proteins, such as dsRNA-dependent protein kinase R (PKR) and 2'5'-oligoadenylate synthetase (OAS)/RNase L. However, it is clear that NS1 also acts directly to modulate other important aspects of the virus replication cycle, including viral RNA replication, viral protein synthesis, and general host-cell physiology. Here, we review the current literature on this remarkably multifunctional viral protein. In the first part of this article, we summarize the basic biochemistry of NS1, in particular its synthesis, structure, and intracellular localization. We then discuss the various roles NS1 has in regulating viral replication mechanisms, host innate/adaptive immune responses, and cellular signalling pathways. We focus on the NS1-RNA and NS1-protein interactions that are fundamental to these processes, and highlight apparent strain-specific ways in which different NS1 proteins may act. In this regard, the contributions of certain NS1 functions to the pathogenicity of human and animal influenza A viruses are also discussed. Finally, we outline practical applications that future studies on NS1 may lead to, including the rational design and manufacture of influenza vaccines, the development of novel antiviral drugs, and the use of oncolytic influenza A viruses as potential anti-cancer agents.
Similar articles
-
The influenza virus NS1 protein as a therapeutic target.Antiviral Res. 2013 Sep;99(3):409-16. doi: 10.1016/j.antiviral.2013.06.005. Epub 2013 Jun 21. Antiviral Res. 2013. PMID: 23796981 Free PMC article. Review.
-
Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.J Virol. 2018 Feb 12;92(5):e02097-17. doi: 10.1128/JVI.02097-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237829 Free PMC article.
-
Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.J Virol. 2017 Apr 28;91(10):e00198-17. doi: 10.1128/JVI.00198-17. Print 2017 May 15. J Virol. 2017. PMID: 28250123 Free PMC article.
-
Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1.J Virol. 2018 Feb 12;92(5):e01875-17. doi: 10.1128/JVI.01875-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237841 Free PMC article.
-
Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs.Int J Mol Sci. 2021 Apr 19;22(8):4242. doi: 10.3390/ijms22084242. Int J Mol Sci. 2021. PMID: 33921888 Free PMC article. Review.
Cited by
-
TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.J Virol. 2013 Apr;87(8):4523-33. doi: 10.1128/JVI.02548-12. Epub 2013 Feb 13. J Virol. 2013. PMID: 23408607 Free PMC article.
-
RNA-Targeting Splicing Modifiers: Drug Development and Screening Assays.Molecules. 2021 Apr 14;26(8):2263. doi: 10.3390/molecules26082263. Molecules. 2021. PMID: 33919699 Free PMC article. Review.
-
Seasonal and pandemic influenza H1N1 viruses induce differential expression of SOCS-1 and RIG-I genes and cytokine/chemokine production in macrophages.Cytokine. 2013 Apr;62(1):151-9. doi: 10.1016/j.cyto.2013.01.018. Epub 2013 Feb 21. Cytokine. 2013. PMID: 23434273 Free PMC article.
-
Adaptive mutation in influenza A virus non-structural gene is linked to host switching and induces a novel protein by alternative splicing.Emerg Microbes Infect. 2012 Nov;1(11):e42. doi: 10.1038/emi.2012.38. Epub 2012 Nov 21. Emerg Microbes Infect. 2012. PMID: 26038410 Free PMC article.
-
Orally Administered Salacia reticulata Extract Reduces H1N1 Influenza Clinical Symptoms in Murine Lung Tissues Putatively Due to Enhanced Natural Killer Cell Activity.Front Immunol. 2016 Mar 31;7:115. doi: 10.3389/fimmu.2016.00115. eCollection 2016. Front Immunol. 2016. PMID: 27066007 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources